Literature DB >> 1980286

Erythrocytes as carriers for L-asparaginase. Methodological and mouse in-vivo studies.

R Kravtzoff1, C Ropars, M Laguerre, J P Muh, M Chassaigne.   

Abstract

L-Asparaginase has been encapsulated in Swiss mouse or human erythrocytes by hypotonic haemolysis followed by isotonic resealing and reannealing. The details of incorporation and properties of carrier erythrocytes are presented. When L-asparaginase loaded into 51Cr-labelled erythrocytes, was infused intravenously, the same half-life was found for asparaginase and 51Cr. In addition, L-asparaginase loaded into erythrocytes was much more effective in eliminating plasma asparagine compared with the same dose of free L-asparaginase injected in solution, during a sustained period (14 days).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1980286     DOI: 10.1111/j.2042-7158.1990.tb06598.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  12 in total

1.  Engineering erythrocytes as a novel carrier for the targeted delivery of the anticancer drug paclitaxel.

Authors:  Gamaleldin I Harisa; Mohamed F Ibrahim; Fars Alanazi; Gamal A Shazly
Journal:  Saudi Pharm J       Date:  2013-01-07       Impact factor: 4.330

Review 2.  Drug delivery by red blood cells: vascular carriers designed by mother nature.

Authors:  Vladimir R Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

Review 3.  Bio-inspired, bioengineered and biomimetic drug delivery carriers.

Authors:  Jin-Wook Yoo; Darrell J Irvine; Dennis E Discher; Samir Mitragotri
Journal:  Nat Rev Drug Discov       Date:  2011-07-01       Impact factor: 84.694

Review 4.  Erythrocytes and the transport of drugs and endogenous compounds.

Authors:  M S Highley; E A De Bruijn
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

5.  Improved pharmacodynamics of L-asparaginase-loaded in human red blood cells.

Authors:  R Kravtzoff; I Desbois; J P Lamagnere; J P Muh; C Valat; M Chassaigne; P Colombat; C Ropars
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

6.  L-Asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL).

Authors:  Young Min Kwon; Hee Sun Chung; Cheol Moon; James Yockman; Yoon Jeong Park; Scott D Gitlin; Allan E David; Victor C Yang
Journal:  J Control Release       Date:  2009-07-03       Impact factor: 9.776

Review 7.  Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.

Authors:  Carlos H Villa; Aaron C Anselmo; Samir Mitragotri; Vladimir Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2016-03-03       Impact factor: 15.470

8.  Nanobiotechnology for the Therapeutic Targeting of Cancer Cells in Blood.

Authors:  Jiahe Li; Charles C Sharkey; Dantong Huang; Michael R King
Journal:  Cell Mol Bioeng       Date:  2015-02-24       Impact factor: 2.321

Review 9.  Ongoing Developments and Clinical Progress in Drug-Loaded Red Blood Cell Technologies.

Authors:  Luigia Rossi; Francesca Pierigè; Mattia Paolo Aliano; Mauro Magnani
Journal:  BioDrugs       Date:  2020-06       Impact factor: 5.807

Review 10.  Vascular Drug Delivery Using Carrier Red Blood Cells: Focus on RBC Surface Loading and Pharmacokinetics.

Authors:  Patrick M Glassman; Carlos H Villa; Anvay Ukidve; Zongmin Zhao; Paige Smith; Samir Mitragotri; Alan J Russell; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Pharmaceutics       Date:  2020-05-09       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.